<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39370858</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1096-9071</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of medical virology</Title><ISOAbbreviation>J Med Virol</ISOAbbreviation></Journal><ArticleTitle>Seroprevalence of enterovirus D68 in Yamagata, Japan, between 1976 and 2019.</ArticleTitle><Pagination><StartPage>e29947</StartPage><MedlinePgn>e29947</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/jmv.29947</ELocationID><Abstract><AbstractText>To clarify the epidemiology of enterovirus D68 (EV-D68), an enterovirus rarely identified in the 20th century, we performed seroepidemiological analysis against EV-D68 using sera collected in 1976, 1985, 1990, 1999, 2009, and 2019, as well as Yamagata isolate (EVD68/Yamagata.JPN/2023-89), in Yamagata, Japan. The neutralizing antibody (Ab)-positive rates for those under 20 years old were 61.0%, 82.5%, 84.3%, 46.7%, 50.5%, and 67.9%, in each year, whereas the rates for those above 20 years old were between 93.4% and 99.1%. Generally, geometric mean titers (GMTs）increased with age among children and the total GMT in each year was 25.4, 49.2, 37.2, 30.8, 29.5, and 33.9, from 1976 to 2019, respectively. The findings in this Yamagata-based study showed that the seroprevalence of EV-D68 over the last four decades has increased with age among children, as a susceptible group, and then reaches a plateau of over approximately 80% among adults. This study clearly revealed that EV-D68 was stably transmitted among children in the 20th century, when EV-D68 detection was quite rare.</AbstractText><CopyrightInformation>© 2024 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Itagaki</LastName><ForeName>Tsutomu</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Yamanobe Pediatric Clinic, Yamagata, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Komabayashi</LastName><ForeName>Kenichi</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-0900-8845</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, Yamagata Prefectural Institute of Public Health, Yamagata, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sasaki</LastName><ForeName>Mika</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Yamagata Prefectural Institute of Public Health, Yamagata, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ogawa</LastName><ForeName>Naomi</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Yamagata Prefectural Institute of Public Health, Yamagata, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seto</LastName><ForeName>Junji</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Yamagata Prefectural Institute of Public Health, Yamagata, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aoki</LastName><ForeName>Yoko</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Yamagata Prefectural Institute of Public Health, Yamagata, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ikeda</LastName><ForeName>Tatsuya</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Yamagata Prefectural Institute of Public Health, Yamagata, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsuzaki</LastName><ForeName>Yoko</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-2757-5886</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases, Yamagata University Faculty of Medicine, Yamagata, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mizuta</LastName><ForeName>Katsumi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Yamagata Prefectural Institute of Public Health, Yamagata, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>The association for reserch on lactic acid bacteria, Japan</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Med Virol</MedlineTA><NlmUniqueID>7705876</NlmUniqueID><ISSNLinking>0146-6615</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016036" MajorTopicYN="N">Seroepidemiologic Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007564" MajorTopicYN="N" Type="Geographic">Japan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030016" MajorTopicYN="Y">Enterovirus D, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="Y">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057134" MajorTopicYN="Y">Antibodies, Neutralizing</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute respiratory infection</Keyword><Keyword MajorTopicYN="N">enterovirus D68</Keyword><Keyword MajorTopicYN="N">epidemiology</Keyword><Keyword MajorTopicYN="N">seroepidemiology</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>7</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>7</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>3</Hour><Minute>44</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39370858</ArticleId><ArticleId IdType="doi">10.1002/jmv.29947</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Schieble JH, Fox VL, Lennette EH. A probable new human picornavirus associated with respiratory disease. Am J Epidemiol. 1967;85:297‐310. doi:10.1093/oxfordjournals.aje.a120693</Citation></Reference><Reference><Citation>Carolyn B, Oberste MS, Pallansch MA Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. In Fields Virology 7th ed. Wolters Kluwer, p86‐128.</Citation></Reference><Reference><Citation>Elrick MJ, Pekosz A, Duggal P, et al Enterovirus D68 molecular and cellular biology and pathogenesis. J Biol Chem. 2021;296:100317. doi:10.1016/j.jbc.2021.100317</Citation></Reference><Reference><Citation>Ikeda T, Mizuta K, Abiko C, et al. Acute respiratory infections due to enterovirus 68 in Yamagata, Japan between 2005 and 2010. Microbiol Immunol. 2012;56:139‐143. doi:10.1111/j.1348-0421.2012.00411.x</Citation></Reference><Reference><Citation>Pabbaraju K, Wong S, Drews SJ, Tipples G, Tellier R. Full genome analysis of enterovirus D‐68 strains circulating in Alberta, Canada. J Med Virol. 2016;88:1194‐1203. doi:10.1002/jmv.24444</Citation></Reference><Reference><Citation>Khetsuriani N, LaMonte‐Fowlkes A, Oberst S, Pallansch MA, Centers for Disease Control and P. Enterovirus Surveillance‐United States, 1970‐2005. Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C.: 2002). 2006;55:1‐20.</Citation></Reference><Reference><Citation>Benschop KSM, Rahamat‐Langendoen JC, van der Avoort HGAM, et al. VIRO‐typeNed, systematic molecular surveillance of enteroviruses in the Netherlands between 2010 and 2014. Euro Surveill. 2016;21:30352. doi:10.2807/1560-7917.ES.2016.21.39.30352.</Citation></Reference><Reference><Citation>National Epidemiological Surveillance of Infectious Diseases, Japan (NESID). [cited 2024 Feb 19], Available (registered members only) from: https://nesid4g.mhlw.hq.admix.go.jp/GKWeb/GKMainServlet.</Citation></Reference><Reference><Citation>Imamura T, Oshitani H. Global reemergence of enterovirus D68 as an important pathogen for acute respiratory infections. Rev Med Virol. 2015;25:102‐114. doi:10.1002/rmv.1820</Citation></Reference><Reference><Citation>Imamura T, Suzuki A, Meijer A. Clusters of acute respiratory illness associated with human enterovirus 68 ‐Asia, Europe, and United States, 2008‐2010. Morb Mortal Wkly Rep. 2011;60:1301‐1304.</Citation></Reference><Reference><Citation>Imamura T. Enterovirus 68 among children with severe acute respiratory infection, the Philippines. Emerging Infect Dis. 2011;17:1430‐1435. doi:10.3201/eid1708.101328</Citation></Reference><Reference><Citation>Shah MM, Perez A, Lively JY, et al. Enterovirus D68‐associated acute respiratory illness ─ new vaccine surveillance network, United States, July–November 2018–2020. MMWR Morb Mortal Wkly Rep. 2021;70:1623‐1628. doi:10.15585/mmwr.mm7047a1</Citation></Reference><Reference><Citation>Itagaki T, Aoki Y, Matoba Y, et al. Clinical characteristics of children infected with enterovirus D68 in an outpatient clinic and the association with bronchial asthma. Infect Dis. 2018;50:303‐312. doi:10.1080/23744235.2017.1400176</Citation></Reference><Reference><Citation>Oermann CM, Schuster JE, Conners GP, Newland JG, Selvarangan R, Jackson MA. Enterovirus D68. A focused review and clinical highlights from the 2014 U.S. outbreak. Ann Am Thorac Soc. 2015;12:775‐781. doi:10.1513/AnnalsATS.201412-592FR.</Citation></Reference><Reference><Citation>Hu YL, Huang LM, Lu CY, Fang TY, Cheng AL, Chang LY. Manifestations of enterovirus D68 and high seroconversion among children attending a kindergarten. J Microbiol Immunol Infect. 2019;52:858‐864. doi:10.1016/j.jmii.2019.04.010</Citation></Reference><Reference><Citation>Kramer R, Sabatier M, Wirth T, et al. Molecular diversity and biennial circulation of enterovirus D68: a systematic screening study in Lyon, France, 2010 to 2016. Euro Surveill. 2018;23(37):1700711. doi:10.2807/1560-7917.ES.2018.23.37.1700711</Citation></Reference><Reference><Citation>Andrés C, Vila J, Creus‐Costa A, et al. Enterovirus D68 in Spain, 2014‐2021. Emerging Infect Dis. 2022;28(7):1327‐1331. doi:10.3201/eid2807.220264</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention. Enterovirus D68. [cited 2024 May 14]; Available from: https://www.cdc.gov/non-polio-enterovirus/about/ev-d68.html.</Citation></Reference><Reference><Citation>Mizuta K, Tanaka W, Komabayashi K, et al. Longitudinal epidemiology of viral infectious diseases combining virus isolation, antigenic analysis, and phylogenetic analysis as well as seroepidemiology in Yamagata, Japan, between 1999 and 2018. Jpn J Infect Dis. 2019;72:211‐223. doi:10.7883/yoken.JJID.2018.500</Citation></Reference><Reference><Citation>Smura T, Ylipaasto P, Klemola P, et al. Cellular tropism of human enterovirus D species serotypes EV‐94, EV‐70, and EV68 in vitro: implications for pathogenesis. J Med Virol. 2010;82:1940‐1949. doi:10.1002/jmv.21894</Citation></Reference><Reference><Citation>Zhang Y, Moore DD, Nix WA, Oberste MS, Weldon WC. Neutralization of enterovirus D68 isolated from the 2014 US outbreak by commercial intravenous immune globulin products. J Clin Virol. 2015;69:172‐175. doi:10.1016/j.jcv.2015.06.086</Citation></Reference><Reference><Citation>Xiang Z, Li L, Ren L, et al. Seroepidemiology of enterovirus D68 infection in China. Emerg Microbes Infect. 2017;6:1‐5. doi:10.1038/emi.2017.14</Citation></Reference><Reference><Citation>Sun S, Gao F, Hu Y, et al. Seroepidemiology of enterovirus D68 infection in infants and children in Jiangsu, China. J Infect. 2018;76:563‐569. doi:10.1016/j.jinf.2018.02.003</Citation></Reference><Reference><Citation>Sun S, Gao F, Hu Y, et al. A cross‐sectional seroepidemiology study of EV‐D68 in China. Emerg Microbes Infect. 2018;7:1‐7. doi:10.1038/s41426-018-0103-4</Citation></Reference><Reference><Citation>Harrison CJ, Weldon WC, Pahud BA, Jackson MA, Oberste MS, Selvarangan R. Neutralizing antibody against enterovirus D68 in children and adults before 2014 outbreak, Kansas City, Missouri, USA. Emerging Infect Dis. 2019;25:585‐588. doi:10.3201/eid2503.180960</Citation></Reference><Reference><Citation>Kamau E, Harvala H, Blomqvist S, et al. Increase in enterovirus D68 infections in young children, United Kingdom, 2006‐2016. Emerging Infect Dis. 2019;25:1200‐1203. doi:10.3201/eid2506.181759</Citation></Reference><Reference><Citation>Karelehto E, Koen G, Benschop K, van der Klis F, Pajkrt D, Wolthers K. Enterovirus D68 serosurvey: evidence for endemic circulation in the Netherlands, 2006 to 2016. Euro Surveill. 2019;24(35):1800671. doi:10.2807/1560-7917.ES.2019.24.35.1800671</Citation></Reference><Reference><Citation>Lee JT, Shih WL, Yen TY, et al. Enterovirus D68 seroepidemiology in Taiwan, a cross sectional study from 2017. PLoS One. 2020;15:e0230180. doi:10.1371/journal.pone.0230180</Citation></Reference><Reference><Citation>Kadji FMN, Nishimura H, Okamoto M, et al. Fluctuations in antibody titers against enterovirus D68 in pediatric sera collected in a community before, during, and after a possible outbreak. Jpn J Infect Dis. 2020;73:55‐57. doi:10.7883/yoken.JJID.2019.056</Citation></Reference><Reference><Citation>Chan YF, Sam IC, Nayan E, Tan XH, Yogarajah T. Seroepidemiology of enterovirus D68 infection in Kuala Lumpur, Malaysia between 2013 and 2015. J Med Virol. 2022;94:2607‐2612. doi:10.1002/jmv.27381</Citation></Reference><Reference><Citation>Pons‐Salort M, Lambert B, Kamau E, et al. Changes in transmission of enterovirus D68 (EV‐D68) in England inferred from seroprevalence data. eLife. 2023;12:e76609. doi:10.7554/eLife.76609</Citation></Reference><Reference><Citation>Seto J, Aoki Y, Komabayashi K, et al. Epidemiology of coronavirus disease 2019 in Yamagata Prefecture, Japan, January‐May 2020: the importance of retrospective contact tracing. Jpn J Infect Dis. 2021;74(6):522‐529. doi:10.7883/yoken.JJID.2020.1073</Citation></Reference><Reference><Citation>Mizuta K, Komabayashi K, Aoki Y, Itagaki T, Ikeda T. Seroprevalence of parechovirus A1, A3, and A4 antibodies in Yamagata, Japan, between 1976 and 2017. J Med Microbiol. 2020;69:1381‐1387. doi:10.1099/jmm.0.001269</Citation></Reference><Reference><Citation>Tanaka W, Komabayashi K, Ikeda Y, Aoki Y, Itagaki T, Mizuta K. Seroprevalence of coxsackievirus A21 neutralizing antibodies in Yamagata, Japan, between 1976 and 2019; coxsackievirus A21 has rarely affected young children. J Med Virol. 2022;94:2877‐2881. doi:10.1002/jmv.27470</Citation></Reference><Reference><Citation>Mizuta K, Itagaki T, Katsushima F, et al. Longitudinal antigenic and seroepidemiological analyses of parechovirus A1 in Yamagata, Japan. J Med Virol. 2023;95(4):e28696. doi:10.1002/jmv.28696</Citation></Reference><Reference><Citation>Oberste MS, Maher K, Schnurr D, et al. Enterovirus 68 is associated with respiratory illness and shares biological features with both the enteroviruses and the rhinoviruses. J Gen Virol. 2004;85:2577‐2584. doi:10.1099/vir.0.79925-0</Citation></Reference><Reference><Citation>Tanaka S, Aoki Y, Matoba Y, et al. Seroepidemiology of human parechovirus types 1, 3, and 6 in Yamagata, Japan, in 2014. Microbiol Immunol. 2016;60:854‐858. doi:10.1111/1348-0421.12456</Citation></Reference><Reference><Citation>Parrott RH, Vargosko AJ, Kim HW, Bell JA, Chanock RM. III. Myxoviruses: parainfluenza. Am J Public Health. 1962;52:907‐917. doi:10.2105/ajph.52.6.907</Citation></Reference><Reference><Citation>Suto T, Yano N, Ikeda M, et al. Respiratory syncytial virus infection and its serologic epidemiology. Am J Epidemiol. 1965;82:211‐224. doi:10.1093/oxfordjournals.aje.a120545</Citation></Reference><Reference><Citation>Imamura T, Okamoto M, Nakakita S, et al. Antigenic and receptor binding properties of enterovirus 68. J Virol. 2014;88:2374‐2384. doi:10.1128/JVI.03070-13</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>